|
Home > Our
Publications > Australian
Outlook> 2007
> January
Reform for PBS
THE Australian Government is making changes to the Pharmaceutical
Benefits Scheme (PBS) to give Australians continued access to new and
expensive medicines while ensuring the PBS remains economically
sustainable into the future.
These changes should make the PBS an even stronger system with the
government paying less for certain medicines without increasing the
cost to patients. In fact, for some medicines, patients should also pay
less.
Over the next few years, Australia will move to a system where the
Government gets better value for many medicines that are coming
off-patent.
There will be a series of price reductions for these medicines and,
over time, the price the government pays will move closer to the actual
price at which these medicines are being supplied.
Patients will continue to have a choice of medicines and to pay only
the standard co payments for a PBS script (currently $4.70 per script
for a concession cardholder and $29.50 a script for others).
There should be more medicines that cost less than $29.50, which will mean cheaper prices to some patients.
A support package will help pharmacy to adjust to the new arrangements.
The package includes increased payments for dispensing medicines plus
incentives to take-up electronic health systems and to dispense
medicines with no additional charges for patients.
It will be simpler for doctors to prescribe certain medicines. From
July next year, around 200 medicines that treat long-term conditions
(such as diabetes or osteoporosis) will be authorised by the doctor
alone without a phone call to Medicare Australia.
These changes will save more than $580 million over the next four
years, growing to $3 billion over the next 10 years. As a result, the
PBS should be well positioned to meet future demand for new and
expensive medicines and patients will continue to have access to these
medicines at a price they can afford. |